000 | 01560nam a2200253Ia 4500 | ||
---|---|---|---|
003 | NULRC | ||
005 | 20250520102818.0 | ||
008 | 250520s9999 xx 000 0 und d | ||
020 | _a9780123820303 | ||
040 | _cNULRC | ||
050 | _aRS 403 .S55 2014 | ||
100 |
_aSilverman, Richard B. _eauthor |
||
245 | 4 |
_aThe organic chemistry of drug design and drug action / _cRichard B. Silverman and Mark W. Holladay |
|
250 | _aThird edition. | ||
260 |
_aSan Diego, California : _bAcademic Press, _cc2014 |
||
300 |
_axvii, 517 pages : _bcolor illustrations ; _c29 cm. |
||
365 | _bUSD58.98 | ||
504 | _aIncludes index. | ||
505 | _aIntroduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems. | ||
520 | _a The Organic chemistry of drug design and drug action, Third edition, represents a unique approach to medicinal chemistry based on physical organic chemical principles and reaction mechanisms that rationalize drug action, which allows the reader to extrapolate those core principles and mechanisms to many related classes of drug molecules. This new edition reflects significant changes in the process of drug design over the last decade. It preserves the successful approach of the previous editions while including significant changes in format and coverage. | ||
650 | _aPHARMACEUTICAL CHEMISTRY | ||
700 |
_aHolladay, Mark W. _eco-author |
||
942 |
_2lcc _cBK |
||
999 |
_c15920 _d15920 |